isradipine has been researched along with Gingival Pocket in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Gingival Pocket: An abnormal extension of a gingival sulcus not accompanied by the apical migration of the epithelial attachment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with nifedipine-induced gingival hyperplasia (GH) often require continued calcium channel blocker therapy." | 9.08 | Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. ( Bednarczyk, EM; Bissada, NF; Carlson, M; Sheehan, H; Westbrook, P, 1997) |
| "Patients with nifedipine-induced gingival hyperplasia (GH) often require continued calcium channel blocker therapy." | 5.08 | Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. ( Bednarczyk, EM; Bissada, NF; Carlson, M; Sheehan, H; Westbrook, P, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Westbrook, P | 1 |
| Bednarczyk, EM | 1 |
| Carlson, M | 1 |
| Sheehan, H | 1 |
| Bissada, NF | 1 |
1 trial available for isradipine and Gingival Pocket
| Article | Year |
|---|---|
Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine.
Topics: Adult; Aged; Antihypertensive Agents; Biopsy; Calcium Channel Blockers; Dental Plaque Index; Evaluat | 1997 |